Christopher Morehouse

3.0k total citations
27 papers, 1.2k citations indexed

About

Christopher Morehouse is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Christopher Morehouse has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Christopher Morehouse's work include Systemic Lupus Erythematosus Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Christopher Morehouse is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Christopher Morehouse collaborates with scholars based in United States, United Kingdom and Belgium. Christopher Morehouse's co-authors include Philip Z. Brohawn, Brandon W. Higgs, Katie Streicher, Bahija Jallal, Laura K. Richman, Koustubh Ranade, Yihong Yao, Fernanda Pilataxi, Russell D. Owen and Peter A. Kiener and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Christopher Morehouse

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Morehouse United States	16	527	418	279	229	217	27	1.2k
Manuel J. Del Rey Spain	18	368 0.7×	320 0.8×	254 0.9×	135 0.6×	263 1.2×	49	1.2k
Shiva Arami United States	16	391 0.7×	286 0.7×	184 0.7×	121 0.5×	236 1.1×	19	951
Peter Middel Germany	24	531 1.0×	351 0.8×	595 2.1×	130 0.6×	151 0.7×	60	1.5k
Xiaoyu Song China	12	273 0.5×	354 0.8×	127 0.5×	172 0.8×	196 0.9×	30	987
Shuji Sumitomo Japan	23	804 1.5×	392 0.9×	339 1.2×	74 0.3×	399 1.8×	70	1.7k
Nathalie Cloutier Canada	17	391 0.7×	929 2.2×	270 1.0×	332 1.4×	143 0.7×	26	1.6k
Efstathios G. Stamatiades United States	9	862 1.6×	452 1.1×	376 1.3×	193 0.8×	59 0.3×	10	1.5k
Zhenke Wen China	25	1.1k 2.1×	718 1.7×	272 1.0×	415 1.8×	377 1.7×	62	1.9k
Carmen Marchiol France	19	708 1.3×	486 1.2×	230 0.8×	151 0.7×	62 0.3×	42	1.4k
Takeo Isozaki Japan	20	324 0.6×	244 0.6×	312 1.1×	82 0.4×	363 1.7×	55	930

Countries citing papers authored by Christopher Morehouse

Since Specialization

Citations

This map shows the geographic impact of Christopher Morehouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Morehouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Morehouse more than expected).

Fields of papers citing papers by Christopher Morehouse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Morehouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Morehouse. The network helps show where Christopher Morehouse may publish in the future.

Co-authorship network of co-authors of Christopher Morehouse

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Morehouse. A scholar is included among the top collaborators of Christopher Morehouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Morehouse. Christopher Morehouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luminari, Stefano, Joshua Brody, Federica Bonello, et al.. (2025). 582 | EPCORITAMAB PLUS BENDAMUSTINE + RITUXIMAB FOR FIRST‐LINE TREATMENT OF FOLLICULAR LYMPHOMA: CLINICAL AND TRANSLATIONAL RESULTS FROM EPCORE NHL‐2 ARM 3. Hematological Oncology. 43(S3). 1 indexed citations

Falchi, Lorenzo, Anna Sureda, Sirpa Leppä, et al.. (2024). Fixed-Duration Epcoritamab + R2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial. Blood. 144(Supplement 1). 342–342. 5 indexed citations

Brody, Joshua, Lorenzo Falchi, Umberto Vitolo, et al.. (2024). Fixed-Duration Epcoritamab in Combination with Bendamustine + Rituximab for First-Line Treatment of Follicular Lymphoma: Initial Results from Epcore NHL-2 Arm 3. Blood. 144(Supplement 1). 1627–1627. 3 indexed citations

Morehouse, Christopher, Anastasia A. Aksyuk, Tyler Brady, et al.. (2023). 2641. Nirsevimab binding-site conservation in RSV F protein between 2015 and 2022: The US OUTSMART-RSV surveillance study. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations

Neupane, Arpan Sharma, Andrew Chojnacki, Fernanda V. S. Castanheira, et al.. (2020). Patrolling Alveolar Macrophages Conceal Bacteria from the Immune System to Maintain Homeostasis. Cell. 183(1). 110–125.e11. 208 indexed citations

Sheth, Siddharth, Christopher Morehouse, E. Ashley Dozier, et al.. (2020). 674 Late antibiotic administration during durvalumab treatment may be associated with clinical benefit. SHILAP Revista de lepidopterología. A404.2–A405. 1 indexed citations

Dutton, Emma E., Claire Willis, Rémi Fiancette, et al.. (2019). Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations. Science Immunology. 4(35). 69 indexed citations

Luheshi, Nadia, Susannah L. Hewitt, Fabien Garçon, et al.. (2019). Abstract 5017: MEDI1191, a novel IL-12 mRNA therapy for intratumoral injection to promote TH1 transformation of the patient tumor microenvironment. Cancer Research. 79(13_Supplement). 5017–5017. 7 indexed citations

Higgs, Brandon W., Christopher Morehouse, Katie Streicher, et al.. (2018). Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab. Clinical Cancer Research. 24(16). 3857–3866. 142 indexed citations

10.

Groves, Christopher J., Jeffrey A. Carrell, R W Grady, et al.. (2018). CD19-positive antibody-secreting cells provide immune memory. Blood Advances. 2(22). 3163–3176. 19 indexed citations

11.

Karnell, Jodi L., Qiming Wang, Shu Wang, et al.. (2017). Autoimmune manifestations in aged mice arise from early-life immune dysregulation. The Journal of Immunology. 198(Supplement_1). 54.1–54.1. 1 indexed citations

12.

Le, Catherine T., Christopher Morehouse, Brian Naiman, et al.. (2015). Synergistic Actions of Blocking Angiopoietin-2 and Tumor Necrosis Factor-α in Suppressing Remodeling of Blood Vessels and Lymphatics in Airway Inflammation. American Journal Of Pathology. 185(11). 2949–2968. 23 indexed citations

13.

Zhu, Wei, Michael Kuziora, Todd Creasy, et al.. (2015). BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing data. Nucleic Acids Research. 44(4). e38–e38. 12 indexed citations

14.

Zhong, Haihong, Christine Fazenbaker, Shannon Breen, et al.. (2014). MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas. Molecular Cancer Therapeutics. 13(11). 2662–2673. 20 indexed citations

15.

Georgantas, Robert W., Katie Streicher, Xiaobing Luo, et al.. (2013). MicroRNA‐206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. Pigment Cell & Melanoma Research. 27(2). 275–286. 61 indexed citations

16.

Streicher, Katie, Wei Zhu, Kim Lehmann, et al.. (2011). A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene. 31(12). 1558–1570. 110 indexed citations

17.

Georgantas, Robert W., Katie Streicher, Wenliang Zhu, et al.. (2011). MicroRNA oncogenes and tumor suppressors controlling malignant melanoma cell growth, apoptosis, migration, and invasion.. Journal of Clinical Oncology. 29(15_suppl). 8549–8549. 2 indexed citations

18.

Yao, Yihong, Laura K. Richman, Brandon W. Higgs, et al.. (2009). Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus. Arthritis & Rheumatism. 60(6). 1785–1796. 224 indexed citations

19.

Morehouse, Christopher & Russell D. Owen. (2000). Exposure of Daudi Cells to Low-Frequency Magnetic Fields Does Not ElevateMYCSteady-State mRNA Levels. Radiation Research. 153(5). 663–669. 17 indexed citations

20.

Morehouse, Christopher & Russell D. Owen. (2000). Exposure to Low-Frequency Electromagnetic Fields Does Not AlterHSP70Expression or HSF-HSE Binding in HL60 Cells. Radiation Research. 153(5). 658–662. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact